New York, New York--(Newsfile Corp. - February 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Kyndryl Holdings, Inc. (NYSE: KD) between August 7, 2024 and February 9, 2026, both dates inclusive (the "Class Period"), of the important April 13, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.SO WHAT: If you purchased Kyndryl securities during the Class Period you may be entitled to compensation without payment of any ...

BENSALEM, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at (215) 638-4847 or by email to howardsmith@howardsmithla ...

Lost Money on Kyndryl Holdings, Inc.(KD)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm [Accessibility Statement] Skip NavigationNEW YORK, Feb. 24, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Kyndryl Holdings, Inc. (NYSE: KD).Shareholders who purchased shares of KD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any rec ...

Core Insights - Kyndryl and the University of Liverpool are collaborating to develop next-generation healthcare technologies using AI, specifically through Kyndryl's Agentic AI Framework and the University's research expertise [1] - The initiative aims to enhance patient interaction and healthcare services, particularly for underserved populations, by creating AI-driven solutions such as conversational AI services [1] - The collaboration aligns with the Liverpool City Region's Life Sciences Innovation Zone, positioning the area as a hub for health and life sciences innovation [1] Group 1: Collaboration Details - The partnership will co-develop blueprints for healthcare technologies, focusing on AI projects that improve patient experiences [1] - Phase one of the collaboration will evaluate conceptual AI projects aimed at enhancing patient interaction and healthcare service utilization [1] - The projects will utilize population health datasets and testbed environments to create a library of innovation-ready models [1] Group 2: Impact and Goals - The collaboration seeks to address significant health disparities in the Liverpool area, where life expectancy can differ by up to 15 years between affluent and disadvantaged communities [1] - The initiative aims to provide more preventive and personalized care while effectively targeting resources to assist vulnerable populations [1] - Kyndryl's AI innovation lab, launched in May 2025, will play a crucial role in developing solutions for real-world health challenges [1] Group 3: Institutional Background - Kyndryl is a leading provider of mission-critical enterprise technology services, operating in over 60 countries [1] - The University of Liverpool is a prominent research-intensive institution with an annual turnover of £708.3 million and a research income of £163.1 million [1] - The University is ranked among the top 150 universities globally and is a member of the Russell Group, reflecting its significant academic influence [1]

New York, New York--(Newsfile Corp. - February 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Kyndryl Holdings, Inc. (NYSE: KD) between August 7, 2024 and February 9, 2026, both dates inclusive (the "Class Period"), of the important April 13, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.SO WHAT: If you purchased Kyndryl securities during the Class Period you may be entitled to compensation without payment of any ...

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Kyndryl Holdings, Inc. (NYSE: KD) between August 7, 2024 and February 9, 2026, both dates inclusive (the “Class Period”), of the important April 13, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Kyndryl securities during the Class Period you may be entitled to compensation without payment of any out of pocket ...

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE: KD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Kyndryl investors who were adversely affected by alleged securities fraud between August 7, 2024 and February 9, 2026. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/kyndryl-holdings-lawsuit- ...

Kyndryl Holdings, Inc. (KD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit [Accessibility Statement] Skip NavigationBENSALEM, Pa., Feb. 23, 2026 /PRNewswire/ -- [The Law Offices of Howard G. Smith] announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE: [KD]).IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN KYNDRYL HOLDINGS, INC. (KD), CONTACT THE LAW OFF ...

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against Kyndryl Holdings, Inc. (NYSE: KD)  (“Kyndryl” or the “Company”) inclusive on behalf of all persons and entities that purchased or otherwise acquired Kyndryl shares August 7, 2024 and February 9, 2026, both dates inclusive (the "Class Period"). Investors have until April 13, 2026, to seek appointments as lead plaintiff. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMI ...

Core Viewpoint - A securities fraud lawsuit has been filed against Kyndryl Holdings, Inc. and certain executives following a significant drop in share price due to internal accounting issues and executive departures [1][2]. Group 1: Company Issues - Kyndryl Holdings' shares fell over 50% in intraday trading on February 9, 2026, after the company announced an internal accounting review and a delay in filing its quarterly report [2]. - The internal review focuses on cash management practices, related disclosures, and internal control over financial reporting, prompted by document requests from the SEC [2]. - Kyndryl does not expect a restatement of its financials but anticipates reporting material weaknesses in internal control over financial reporting for FY25 and the first three quarters of FY26 [2]. Group 2: Lawsuit Details - The lawsuit alleges that Kyndryl made false and misleading statements regarding its financial statements, internal controls, and the timely filing of its Quarterly Report on Form 10-Q for the quarter ended December 31, 2025 [3]. - It is claimed that Kyndryl lacked adequate internal controls and materially understated issues related to them, leading to misleading statements about the company's business and prospects [3]. Group 3: Investor Information - Investors who purchased Kyndryl Holdings common stock between August 7, 2024, and February 9, 2026, may be eligible to participate in the lawsuit, regardless of whether they have sold their shares [4]. - The deadline to seek appointment as lead plaintiff is April 13, 2026, and a class has not yet been certified [5]. Group 4: Whistleblower Information - Individuals with non-public information about Kyndryl Holdings are encouraged to assist in the investigation or file a report with the SEC under the whistleblower program, potentially receiving rewards of up to 30% of any successful recovery [6]. Group 5: Legal Representation - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [7].